Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_assertion type Assertion NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_head.
- NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_assertion description "[In ER-negative and postmenopausal patients, EGFR gene amplification was strongly associated with worse recurrence-free survival (P = 0.0087, P = 0.0149, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_provenance.
- NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_assertion evidence source_evidence_literature NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_provenance.
- NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_assertion SIO_000772 18067636 NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_provenance.
- NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_assertion wasDerivedFrom befree-20140225 NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_provenance.
- NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_assertion wasGeneratedBy ECO_0000203 NP161816.RACadtEabpe-Lskf-lvaThnBdkp-V4X5177Xdt0eWq7DQ130_provenance.